Tuesday, 16 October 2018

Process Spectroscopy Market Size Worth $25.10 Billion By 2025|Key Industry Participants Danaher Corporation, Shimadzu Corporation

San Francisco,17 October 2018: The global process spectroscopy market size is estimated to reach USD 25.10 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 7.5% during the forecast period. Growing efforts in the pharmaceutical industry to undertake advanced research and development is leading to increased adoption of various spectroscopy techniques over the forecast period.

The technology is anticipated to witness healthy growth owing to rising awareness regarding the importance of product quality among industries. Reducing operational expenditure is another factor expected to drive the market over the forecast period. Furthermore, significant R&D activities are undertaken, which have led to several drug discoveries. Increasing number of drug discovery processes is leading to a greater number of treatment options for various diseases. Treatment options include drugs as well as non-drug therapies such as surgeries and radiations.
Surging demand for spectroscopic techniques and related equipment installations across the globe are poised to augment the market over the forecast period. The process spectroscopy market is likely to witness tremendous growth over the forecast years, owing to increasing awareness of quality spectroscopic devices among end-use industries.
Technological advancements necessitate matching international quality standards, such as ISO or Six Sigma, and cost- & time-saving approaches of companies are encouraging adoption of process spectroscopic instruments. Increasing availability of counterfeit products in the market are mandating governments globally to educate masses about quality products and quality standards.
Molecular spectroscopy is a technology that is widely adopted across different application sectors including pharmaceuticals and food & agriculture. The molecular spectroscopy segment held the largest share in the market in 2017 and is projected to maintain its dominance over the forecast period.
Additionally, the Raman spectroscopy technology is gaining popularity across the agricultural sector owing to its ability to allow non-destructive extraction of chemicals and physical information about samples of fruits, vegetables, and food grains and it helps in rapid analysis of these food items. Hence, these advantages of spectroscopic techniques are attracting new applications across the food & agricultural sector, ultimately fostering the growth of the global process spectroscopy market.
Although, the considerable initial investment required for installation of spectroscopic equipment have forced industry players to pass the cost onto consumers, thereby increasing prices of process spectroscopic instruments. However, emergence of cost-effective technologies in the coming years can lead to reduction in prices of these instruments.
Access Research Report of Process Spectroscopy Market @ www.grandviewresearch.com/industry-analysis/process-spectroscopy-market

Further key findings from the report suggest:
·       Several law enforcement authorities and government regulatory bodies imposed for betterment of product quality in the food & agriculture sector are encouraging the manufacturing & packaging industries to adopt measures to meet imposed specifications
·       The adoption of various spectroscopic techniques is expected to rise significantly over the forecast period in the pharmaceutical and food & agriculture segments
·       The Asia Pacific market is estimated to witness tremendous growth over the forecast period
·       The key industry participants include ABB Group, Buchi Labortechnik AG, Danaher Corporation, Shimadzu Corporation, and Sartorius AG
·       The prominent strategies followed by large market players include signing partnerships or distribution agreements and mergers & acquisitions along with enriching their portfolios by involving in intense R&D practices.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/emerging-and-next-generation-technologies
Grand View Research has segmented the global process spectroscopy market based on technology, application, component, and region:
Process Spectroscopy Technology Outlook (Revenue, USD Billion, 2014 - 2025)
·         Molecular Spectroscopy
·         Mass Spectroscopy
·         Atomic Spectroscopy
Process Spectroscopy Application Outlook (Revenue, USD Billion, 2014 - 2025)
·         Polymer
·         Oil & Gas
·         Pharmaceuticals
·         Food & Agriculture
·         Chemicals
·         Water & Wastewater 
·         Pulp & Paper 
·         Metal & Mining 
·         Others
Process Spectroscopy Component Outlook (Revenue, USD Billion, 2014 - 2025)
·         Hardware
·         Software
Process Spectroscopy Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         South America
·         Middle East & Africa (MEA)
Access Press Release of Process Spectroscopy Market@ www.grandviewresearch.com/press-release/global-process-spectroscopy-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Pharmacy Inventory Management Software Solutions and Cabinets Market Size is Expected to Reach $7.16 Billion by 2025

San Francisco,17 October 2018: The global pharmacy inventory management software solutions and cabinets market size is expected to reach USD 7.16 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting an 8.6% CAGR during the forecast period. Increasing number of dispensed prescriptions, growing adoption of pharmacy automation systems, and rising incidence of medication errors are some of the key drivers for this market. Technological advancements in automated dispensing cabinets design are also expected to positively impact market growth in the coming years.

Rising number of retail, mail order, and long-term care (LTC) pharmacies propel demand for inventory management software and systems in order to dispense high volume of medications. Rising pressure by governments to minimize medication costs is further expected to drive demand for these software and cabinets, as they aid in reduction of excess inventory costs. Increasing demand for efficient workflow in hospitals and pharmacies is also contributing toward market growth.
Demand for automated dispensing cabinets is increasing in retail pharmacies owing to increasing workload on pharmacists, coupled with surging need for effective patient counselling. In addition, rising government initiatives towards improvement in healthcare infrastructure and growing healthcare expenditure in developing countries are positively influencing market growth.
Access Research Report of Pharmacy Inventory Management Software Solutions and Cabinets Market@ www.grandviewresearch.com/industry-analysis/pharmacy-inventory-management-software-solutions-cabinets-market

Further key findings from the report suggest:
·       Pharmacy inventory management systems/cabinets in retail pharmacies emerged as the leading segment in terms of revenue in 2017 owing to rising number of retail pharmacies and growing number of prescriptions
·       By mode of operation, decentralized systems/cabinets accounted for the largest revenue share in 2017 owing to rising incidence of medication errors and increasing number of dispensed prescriptions
·       In terms of geography, North America dominated the global market in 2017 in terms of revenue and Asia Pacific is expected to register the highest growth rate over the forecast period
·       Omnicell, Inc.; BD; Talyst, LLC; and ARxIUM are the major players operating in the market. This market is dominated by the presence of both multinational companies and small players.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the global pharmacy inventory management software solutions and cabinets market on the basis of end use, mode of operation, and region:
Pharmacy Inventory Management Software Solutions and Cabinets End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Independent pharmacies
o    Software Solutions
o    Cabinets
·         Hospital pharmacies
o    Software Solutions
o    Cabinets
·         Long-term care centers
o    Software Solutions
o    Cabinets
Pharmacy Inventory Management Software Solutions and Cabinets Mode of Operation Outlook (Revenue, USD Million, 2014 - 2025)
·         Centralized systems
o    Software Solutions
o    Cabinets
·         Decentralized systems
o    Software Solutions
o    Cabinets
Pharmacy Inventory Management Software Solutions and Cabinets Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    U.K
o    Germany
·         Asia-Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East Africa
o    South Africa
Access Press Release of Pharmacy Inventory Management Software Solutions and Cabinets Market@ www.grandviewresearch.com/press-release/global-pharmacy-inventory-management-software-solutions-cabinets-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cancer Biomarkers Market Expected to Witness a CAGR of 14.3% through 2025|Key Industry Participants QIAGEN; Thermo Fisher Scientific Inc.


San Francisco,16 October 2018: The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.
People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.
Access Research Report of Cancer Biomarkers Market @ www.grandviewresearch.com/industry-analysis/cancer-biomarker-market

Further Key findings from the study suggest:
·       Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer
·       Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers
·       Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016
·       However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development
·       Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity
·       The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period
·       North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region
·       Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%
·       Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the cancer biomarkers market by type, biomolecule, applications, and region:
Cancer Biomarker Type Outlook (Revenue, USD Billion, 2014 - 2025)
·         Breast cancer
·         Prostate cancer
·         Colorectal cancer
·         Cervical cancer
·         Liver cancer
·         Lung cancer
·         Others
Cancer Biomarker Biomolecule Outlook (Revenue, USD Billion, 2014 - 2025)
·         Genetic Biomarkers
·         Epigenetic Biomarkers
·         Metabolic Biomarkers
·         Proteomic Biomarkers
·         Others
Cancer Biomarker Application Outlook (Revenue, USD Billion, 2014 - 2025)
·         Drug discovery and Development
·         Diagnostics
·         Personalized medicine
·         Others
Cancer Biomarker Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
Access Press Release of Cancer Biomarkers Market@ www.grandviewresearch.com/press-release/global-cancer-biomarkers-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

License Management Market Size, Trends, and Growth Forecast 2033

  License management is the process of tracking, organizing, and controlling software licenses within an organization. As businesses increas...